Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Dow
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson

Last Updated: September 26, 2022

Drugs in MeSH Category Androgen Antagonists


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Waylis Therap FLUTAMIDE flutamide CAPSULE;ORAL 075298-001 Sep 18, 2001 RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan FLUTAMIDE flutamide CAPSULE;ORAL 076224-001 May 9, 2003 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Rx FLUTAMIDE flutamide CAPSULE;ORAL 075818-001 Sep 18, 2001 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Actavis Labs Fl Inc FLUTAMIDE flutamide CAPSULE;ORAL 075820-001 Sep 18, 2001 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cipla FLUTAMIDE flutamide CAPSULE;ORAL 075780-001 Sep 19, 2001 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Sign up for a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Harvard Business School
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group